UTHealth's Principal Investigator for RESPECT Trial on PFO Closure and Stroke, Available for Interviews
Article ID: 595405
Released: 25-Oct-2012 10:40 AM EDT
Source Newsroom: University of Texas Health Science Center at Houston
Dr. Richard Smalling, M.D., Ph.D, FACCDirector of Interventional Cardiovascular Medicine, Division of Cardiovascular MedicineThe University of Texas Medical School at Houston and the Memorial Hermann Heart and Vascular Institute
Dr. Smalling is a native Texan who received his undergraduate degree in Aerospace Engineering, master’s degree in Bio-Medical Engineering, and Ph.D. from The University of Texas. He is an AOA graduate of The University of Texas Medical School at Houston and completed residency training and cardiology fellowship at University of California - San Diego. Dr. Smalling is board certified in internal medicine, cardiovascular medicine, and interventional cardiology and is past president of the American Heart Association, Texas Affiliate. He has been honored as a Distinguished Alumnus of both The University of Texas Medical School at Houston and the College of Engineering, University Texas at Austin.
Named an America’s Top Doctor for the past seven years, Dr. Smalling has received several awards from the American Heart Association including the Distinguished Service Award from the Texas Affiliate in 1990. He is on the editorial boards of Catheterization and Cardiovascular Interventions, The Journal of Interventional Cardiology, and is a past Associate Editor for Circulation. In addition, he holds several patents and has formed a company, Windmill Cardiovascular Systems, to produce a new implantable left ventricular assist device.
Dr. Smalling specializes in coronary artery angiography and revascularization, treatment of adult congenital heart disease percutaneously, and the treatment of valvular heart disease percutaneously. He has significant expertise in treatment of peripheral vascular disease including carotid stenting, percutaneous endovascular repair of abdominal aortic aneurysm, renal, iliac, femoral and below-knee angioplasty and stenting. Additionally, his team is experienced in utilizing left ventricular assist devices to support high risk coronary angioplasty and complicated valve treatment procedures.
His research interests include advanced intravascular imaging procedures for coronary artery disease and mechanical and pharmacologic reduction of ischemic myocardial injury. Clinically, his team is actively pursuing the role of very early treatment of patients with acute myocardial infarction and evaluating new percutaneous methodologies for treating valvular heart disease.
Dr. Smalling is the author of over 208 Scientific Papers, 141 abstracts, 24 book chapters, 2 books, and more than 15 web based CME articles.